Atul C PandeSummaryAffiliation: Pfizer Global Research and Development Country: USA Publications
|
Detail Information
Publications
Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter studyAtul C Pande
Pfizer Global Research and Development, New London, CT 06320, USA
J Clin Psychopharmacol 24:141-9. 2004..Somnolence and dizziness were the most frequently occurring adverse events among patients receiving pregabalin 600 mg/d. In conclusion, pregabalin 600 mg/d was an effective and well-tolerated treatment of social anxiety disorder...- A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorderDouglas E Feltner
Pfizer Global Research and Development, Ann Arbor Laboratories, 2800 Plymouth Road, Ann Arbor, MI 48105, USA
J Clin Psychopharmacol 23:240-9. 2003..This study supports the hypothesis that pregabalin is effective and safe in short-term therapy for GAD. More studies are needed to determine the best dosing regimen to optimize efficacy and tolerability... - Long-term efficacy of pregabalin in generalized anxiety disorderDouglas Feltner
Pfizer Global Research and Development, Ann Arbor, Missouri, USA
Int Clin Psychopharmacol 23:18-28. 2008..2%), headache (10.1 vs. 11.2%), and somnolence (6.0 vs. 0%). No safety concerns were identified with long-term treatment. The study indicates that pregabalin is an effective treatment for the prevention of relapse in patients with GAD... - Pregabalin in generalized anxiety disorder: a placebo-controlled trialAtul C Pande
Pfizer Global Research and Development, Ann Arbor Laboratories, MI, USA
Am J Psychiatry 160:533-40. 2003..In short-term treatment, pregabalin does not appear to have the withdrawal symptoms associated with the benzodiazepines... - Efficacy of pregabalin in the treatment of generalized anxiety disorder: double-blind, placebo-controlled comparison of BID versus TID dosingRobert B Pohl
University Psychiatric Center, Wayne State University, Detroit, MI 48207, USA
J Clin Psychopharmacol 25:151-8. 2005..This study demonstrates that pregabalin is an effective treatment of generalized anxiety disorder, with BID dosing showing similar efficacy and comparable tolerability with TID dosing... - Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolamKarl Rickels
Department of Psychiatry, University of Pennsylvania, Philadelphia 19104 3309, USA
Arch Gen Psychiatry 62:1022-30. 2005..Pregabalin inhibits release of excess excitatory neurotransmitters, presumably by binding to the alpha2-delta subunit protein of widely distributed voltage-dependent calcium channels in the brain and spinal cord... - Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxineStuart A Montgomery
Imperial College School of Medicine, London, UK
J Clin Psychiatry 67:771-82. 2006..The current study compared the efficacy and safety of pregabalin and venlafaxine in patients diagnosed with moderate to severe GAD...